Cardiovascular Drugs Market – Anticoagulant Innovation Reducing Thrombotic Events
Market Overview The cardiovascular drugs market continues to expand as anticoagulant innovation provides safer and more convenient alternatives to traditional vitamin K antagonists for preventing thrombotic events in atrial fibrillation, venous thromboembolism, and post-surgical contexts. Direct oral anticoagulants have transformed clinical practice by offering fixed dosing without routine...
0 Comments 0 Shares 239 Views 0 Reviews